Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.053x

Jiangsu Nhwa Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a cash flow conversion efficiency ratio of 0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥425.83 Million ≈ $62.31 Million USD) by net assets (CN¥8.08 Billion ≈ $1.18 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)

Cash flow conversion efficiency of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. This chart illustrates how Jiangsu Nhwa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Jiangsu Nhwa Pharmaceutical Co Ltd for real-time trading data and today's change.

Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu Nhwa Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Nhwa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Nhwa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Jiangsu Nhwa Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Star Health and Allied Insurance Company Limited
NSE:STARHEALTH
-0.032x
Veracyte Inc
NASDAQ:VCYT
0.033x
Avient Corp
NYSE:AVNT
-0.014x
Liechtensteinische Landesbank AG
SW:LLBN
0.034x
Lepu Medical Tech Beijing
SHE:300003
0.024x
Hafnia Limited
NYSE:HAFN
0.051x
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
-0.165x
Hiwin Technologies Corp
TW:2049
0.050x

Annual Cash Flow Conversion Efficiency for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. Review Jiangsu Nhwa Pharmaceutical Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.03 Billion
≈ $1.17 Billion
CN¥1.08 Billion
≈ $157.80 Million
0.134x +6.65%
2024-12-31 CN¥7.27 Billion
≈ $1.06 Billion
CN¥916.13 Million
≈ $134.06 Million
0.126x -19.93%
2023-12-31 CN¥6.41 Billion
≈ $938.00 Million
CN¥1.01 Billion
≈ $147.55 Million
0.157x +2.01%
2022-12-31 CN¥5.58 Billion
≈ $817.07 Million
CN¥861.02 Million
≈ $125.99 Million
0.154x +7.85%
2021-12-31 CN¥4.90 Billion
≈ $717.57 Million
CN¥701.12 Million
≈ $102.60 Million
0.143x -52.98%
2020-12-31 CN¥4.11 Billion
≈ $600.76 Million
CN¥1.25 Billion
≈ $182.67 Million
0.304x +258.24%
2019-12-31 CN¥3.60 Billion
≈ $527.50 Million
CN¥305.97 Million
≈ $44.77 Million
0.085x -37.93%
2018-12-31 CN¥2.96 Billion
≈ $432.87 Million
CN¥404.52 Million
≈ $59.19 Million
0.137x -25.59%
2017-12-31 CN¥2.46 Billion
≈ $360.17 Million
CN¥452.35 Million
≈ $66.19 Million
0.184x +40.84%
2016-12-31 CN¥2.12 Billion
≈ $310.80 Million
CN¥277.14 Million
≈ $40.55 Million
0.130x +16.75%
2015-12-31 CN¥1.83 Billion
≈ $267.39 Million
CN¥204.24 Million
≈ $29.89 Million
0.112x -26.13%
2014-12-31 CN¥1.06 Billion
≈ $154.97 Million
CN¥160.24 Million
≈ $23.45 Million
0.151x -34.89%
2013-12-31 CN¥836.21 Million
≈ $122.36 Million
CN¥194.33 Million
≈ $28.44 Million
0.232x +2.88%
2012-12-31 CN¥682.44 Million
≈ $99.86 Million
CN¥154.16 Million
≈ $22.56 Million
0.226x +54.92%
2011-12-31 CN¥556.01 Million
≈ $81.36 Million
CN¥81.08 Million
≈ $11.86 Million
0.146x +9.15%
2010-12-31 CN¥462.56 Million
≈ $67.69 Million
CN¥61.79 Million
≈ $9.04 Million
0.134x -13.66%
2009-12-31 CN¥396.00 Million
≈ $57.95 Million
CN¥61.27 Million
≈ $8.97 Million
0.155x +14.38%
2008-12-31 CN¥343.75 Million
≈ $50.30 Million
CN¥46.50 Million
≈ $6.80 Million
0.135x -57.54%
2007-12-31 CN¥152.39 Million
≈ $22.30 Million
CN¥48.55 Million
≈ $7.10 Million
0.319x +26.12%
2006-12-31 CN¥122.67 Million
≈ $17.95 Million
CN¥30.99 Million
≈ $4.53 Million
0.253x +259.29%
2005-12-31 CN¥125.74 Million
≈ $18.40 Million
CN¥8.84 Million
≈ $1.29 Million
0.070x --

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.38 Billion
CN¥23.07 Billion CNY
Market Cap Rank
#4464 Global
#658 in China
Share Price
CN¥22.77
Change (1 day)
+1.61%
52-Week Range
CN¥18.23 - CN¥25.64
All Time High
CN¥31.19
About

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin… Read more